A Certificate of Analysis (COA) is the analytical fingerprint that accompanies a research peptide, summarizing what a laboratory measured about a specific lot. Learning how to read a peptide COA means understanding three core questions the document answers: is the material what the label says it is (identity), how much of it is the intended sequence versus everything else (purity), and what test methods produced those numbers. This guide walks through each section so a researcher can interpret a COA critically rather than treating the top-line purity figure as the whole story.
Why a COA exists
Peptides are assessed against a series of analytical tests, and their quality is judged on a defined set of critical quality attributes rather than a single measurement. Regulatory and pharmacopeial frameworks for synthetic peptides emphasize the use of multiple orthogonal methods, because no one technique captures identity, purity, and content at once (Kuril et al., 2024). A COA is the condensed record of that testing for one production lot. Two vials from different lots of the same compound can carry meaningfully different COAs, which is why the lot or batch number near the top of the page matters as much as the compound name.
How to read a peptide COA line by line
Most COAs are organized as a table of attributes, each paired with a specification (the acceptance range), a result (what was measured), and often the method used. Reading it well means checking that a result falls inside its stated specification and noticing when an expected test is simply absent.
Identity: confirming the sequence
Because the intended sequence of a synthetic peptide is known in advance, identity testing is used to confirm that the molecule in the vial matches it. Mass spectrometry is well suited to this task; techniques such as MALDI-TOF-MS and LC-MS compare the measured molecular mass against the theoretical mass calculated from the sequence (Prabhala et al., 2015). On a COA this usually appears as an “observed mass” or “molecular weight” line alongside a “theoretical” value. When the two agree within the instrument’s tolerance, the identity is considered confirmed. Larger or more complex peptides may warrant additional orthogonal identity methods, and reference-standard programs commonly combine mass spectrometry, NMR, and chromatographic retention to establish identity with confidence (McCarthy et al., 2023).
Purity: what the percentage actually describes
Purity is typically reported by reversed-phase high-performance liquid chromatography (RP-HPLC), expressed as the percent area of the main peak relative to total peak area at a specified wavelength. It is important to read purity as a chromatographic area percentage under one set of conditions, not an absolute statement of composition. A single HPLC method can also under-report impurities when a contaminant co-elutes with the target peak; peptide analysts specifically guard against this, and advanced approaches such as two-dimensional LC coupled to mass spectrometry exist precisely to detect species hiding beneath the main peak (Stoll et al., 2023). A high purity figure from one method is therefore strongest when supported by an identity method and, ideally, a description of the gradient and column used.
Impurities and related substances
Beyond the headline number, a thorough COA may itemize related substances: sequence deletions, amino acid substitutions, truncations, or stereoisomers arising from synthesis. Studies characterizing synthetic peptide reference materials have identified dozens of distinct structurally related impurities in a single preparation, each quantified individually (Li et al., 2018). A COA that lists named or grouped impurities with individual limits gives a fuller picture than one reporting only a lump “purity” value.
Water, counter-ion, and content
Lyophilized peptides are rarely pure peptide by mass. Water content (often by Karl Fischer titration), residual counter-ions such as trifluoroacetate or acetate, and residual solvents all occupy part of the vial’s weight. “Peptide content” or “net peptide” reflects the fraction of the total mass that is actually peptide, and value-assignment for reference standards uses a mass-balance approach that accounts for these components (McCarthy et al., 2023). This is why chromatographic purity and peptide content are two different numbers, and both belong on a complete COA.
Reading test methods and appearance
The method column is not filler. Knowing that purity came from RP-HPLC with UV detection, that mass was measured by ESI-LC-MS, and that water was determined by Karl Fischer tells a researcher how each result was generated and what its limitations are. Appearance, solubility, and lot and analysis dates round out the document. A COA with an unstated method, a missing lot number, or a purity figure divorced from any identity confirmation is harder to interpret with confidence, regardless of how favorable the number looks.
Putting it together
A well-constructed peptide COA is read as an integrated set of orthogonal measurements: identity that confirms the sequence, purity that quantifies the main component under a stated method, an impurity profile that accounts for the remainder, and content and water data that explain the vial’s total mass. Interpreting these together, rather than fixating on one percentage, is what distinguishes careful documentation literacy from label-reading.
References
- Kuril AK, Saravanan K, Subbappa PK. Analytical considerations for characterization of generic peptide product: A regulatory insight. Anal Biochem. 2024;694:115633. https://doi.org/10.1016/j.ab.2024.115633
- McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40(6):1317-1328. https://doi.org/10.1007/s11095-023-03493-1
- Prabhala BK, Mirza O, Hojrup P, Hansen PR. Characterization of Synthetic Peptides by Mass Spectrometry. Methods Mol Biol. 2015;1348:77-82. https://doi.org/10.1007/978-1-4939-2999-3_9
- Stoll DR, Sylvester M, Euerby MR, Buckenmaier SMC, Petersson P. A strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography using 2D-LC coupled to mass spectrometry (Part II). J Chromatogr A. 2023;1693:463873. https://doi.org/10.1016/j.chroma.2023.463873
- Li M, Josephs RD, Daireaux A, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Anal Bioanal Chem. 2018;410(20):5059-5070. https://doi.org/10.1007/s00216-018-1155-y
Research Use Only. The compounds and documentation discussed here are intended solely for laboratory and scientific research. They are not drugs, dietary supplements, or products for human or animal consumption, diagnosis, treatment, or the prevention of any condition. Nothing in this article is medical, clinical, or dosing guidance. Information is provided for educational purposes to support quality-documentation literacy, and citations describe what published analytical research has investigated.